Rangeley Capital, LLC Pep Gen Inc. Transaction History
Rangeley Capital, LLC
- $93.4 Billion
- Q1 2025
A detailed history of Rangeley Capital, LLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Rangeley Capital, LLC holds 15,000 shares of PEPG stock, worth $23,100. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$23,100% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding PEPG
# of Institutions
71Shares Held
25MCall Options Held
19.6KPut Options Held
80.8K-
Ra Capital Management, L.P. Boston, MA10.7MShares$16.5 Million0.31% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.68MShares$4.12 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.66MShares$2.56 Million0.1% of portfolio
-
Viking Global Investors LP1.48MShares$2.28 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.35MShares$2.08 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $36.4M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...